Albumin-coated Nanocrystals
Albumin-coated pharmaceutical nanocrystals containing over 85 percent active ingredients enhance drug effectiveness, bioavailability, and tumor targeting by evading immune system detection.
Researchers at Purdue University have developed a method to produce pharmaceutical nanocrystals comprised of more than 85 percent of their respective active ingredients. These nanocrystals are coated with albumin to prevent the immune response and allow the nanocrystals to target cancerous cells unhindered. These nanocrystals have the potential to increase the effectiveness of a wide range of drugs as they contain a much greater percentage of active ingredients, allow for increased bioavailability, and avoid immune recognition.
Advantages:
-Increases bioavailability of insoluble drugs
-Fewer adverse effects
-Avoids immune recognition
Potential Applications:
-Drug formulation
Related Publications:
J. Park, et al., Albumin-coated nanocrystals for carrier-free delivery of paclitaxel. Journal of Controlled Release (2016). http://dx.doi.org/10.1016/j.jconrel.2016.12.040
Enhancing Docetaxel Delivery to Multidrug-Resistant Cancer Cells with Albumin-Coated Nanocrystals
Sheryhan F. Gad, Joonyoung Park, Ji Eun Park, Gihan N. Fetih, Sozan S. Tous, Wooin Lee, and Yoon Yeo
Molecular Pharmaceutics 2018 15 (3), 871-881
DOI: 10.1021/acs.molpharmaceut.7b00783
https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.7b00783
A Comparative In Vivo Study of Albumin-Coated Paclitaxel Nanocrystals and Abraxane
Joonyoung Park, Ji Eun Park, Victoria E. Hedrick, Karl V. Wood, Connie Bonham, Wooin Lee, Yoon Yeo,
First published: 23 March 2018
https://doi.org/10.1002/smll.201703670
Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation,
Journal of Controlled Release,
Ji Eun Park, Joonyoung Park, Yearin Jun, Yunseok Oh, Gongmi Ryoo, Yoo-Seong Jeong, Hytham H. Gadalla, Jee Sun Min, Jung Hwan Jo, Myung Geun Song, Keon Wook Kang, Soo Kyung Bae, Yoon Yeo, Wooin Lee,
Volume 302, 2019,
Pages 148-159,
ISSN 0168-3659,
https://doi.org/10.1016/j.jconrel.2019.04.006.
(https://www.sciencedirect.com/science/article/pii/S0168365919301981)
TRL: 3
Intellectual Property:
Provisional-Patent, 2016-06-16, United States | Utility Patent, 2017-06-15, United States
Keywords: pharmaceutical nanocrystals, active ingredients, albumin-coated, immune recognition, targeted delivery, bioavailability, insoluble drugs, drug formulation, paclitaxel, docetaxel